2024-03-29T09:15:33Z
https://niigata-u.repo.nii.ac.jp/oai
oai:niigata-u.repo.nii.ac.jp:00024235
2022-12-15T03:54:19Z
453:456
471:537:538:1236
3)-2 膜型血漿分離法によるplasmapheresis(シンポジウム 血液製剤の輸血適応と問題点, 1986年, 第420回新潟医学会例会)
3)-2 膜型血漿分離法によるplasmapheresis(シンポジウム 血液製剤の輸血適応と問題点, 1986年, 第420回新潟医学会例会)
Membrane Plasmapheresis (Indications and Problems in Tranfusion of Blood Components as of 1986)
下条, 文武
中野, 正明
荒川, 正昭
membrane plasmapheresis
double filtration plasmapheresis
rheumatic arthritis
膜型プラスマフェレーシス
二重膜濾過プラスマフェレーシス
慢性関節リウマチ
Membrane plasmapheresis is a new therapeutic tool to control patients with autoimmune and metabolic disorders. Double filtration plasmapheresis, in which two membrane filters with different pore size are utilized to selectively remove pathogenic macromolecules in plasma, has been found to be safe and efficient system of membrane plasmapheresis for various autoimmune diseases. In Niigata University Hospital, 30 patients with autoimmune and hyperlipidemic diseases have been treated with double filtration plasmapheresis and 21 patients with metabolic diseases have been done with single membrane plasma exchange using fresh-frozen plasma. We have observed no major side effects in this treatment. Plasmapheresis presently is an appropriate symptomatic treatment, and future research must undertake to clarify the pathogenic factors which should be removed from the blood.
新潟医学会
1987-03
jpn
departmental bulletin paper
http://hdl.handle.net/10191/36374
https://niigata-u.repo.nii.ac.jp/records/24235
AN00182415
00290440
新潟医学会雑誌
新潟医学会雑誌
101
3
165
167
https://niigata-u.repo.nii.ac.jp/record/24235/files/101(3)_165-167.pdf
application/pdf
221.0 kB
2019-08-19